The proteolytic activity of separase in BCR-ABL-positive cells is increased by imatinib.
Haaß W; Stehle M; Nittka S; Giehl M; Schrotz-King P; Fabarius A; Hofmann WK; Seifarth W; Plos One, 2012, vol. 7, issue 8, p e42863, ISSN 19326203. ISBN 19326203.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef